Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 750
Single User License Price INR 50588
Corporate User License Price USD 2250
Corporate User License Price INR 151763
Site License Price USD 1500
Site License Price INR 101175
Request a Quote

Report Title

Sedia Biosciences Corp - Product Pipeline Analysis, 2018 Update

Quote Request for License Type
License Type Price  
Single User License USD 750
Site License USD 1500
Enterprise Wide License USD 2250
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Sedia Biosciences Corp - Product Pipeline Analysis, 2018 Update


Quote Request for License Type
License Type Price  
Single User License USD 750
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Sedia Biosciences Corp - Product Pipeline Analysis, 2018 Update

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Sedia Biosciences Corp - Product Pipeline Analysis, 2018 Update



Executive Summary

Summary

Sedia Biosciences Corp (SBC) is a medical device company that offers diagnostic products. The company provides medical devices, diagnostic devices, HIV incidence products, rapid point of care assays and specimen collection devices. It offers diagnostic products, epidemiological products, clinical products, rapid point of care diagnostic assays, novel epidemiological disease surveillance assays, monitoring devices and other public health tools. SBC provides services such as technology licensing, commercialization, medical device manufacturing and distributing, diagnostic testing, monitoring, white labeling, and technology transfer and development services. The company markets its products in the US and other European and Asian countries. SBC is headquartered in Portland, Oregon, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Sedia Biosciences Corp

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Sedia Biosciences Corp Company Overview 4

Sedia Biosciences Corp Company Snapshot 4

Sedia Biosciences Corp Pipeline Products and Ongoing Clinical Trials Overview 4

Sedia Biosciences Corp-Pipeline Analysis Overview 6

Sedia Biosciences Corp-Key Facts 6

Sedia Biosciences Corp-Major Products and Services 7

Sedia Biosciences Corp Pipeline Products by Development Stage 8

Sedia Biosciences Corp Pipeline Products Overview 10

Asante Rapid Hepatitis B sAg (Hepatitis B Surface Antigen) Blood/Oral Fluid Test 10

Asante Rapid Hepatitis B sAg (Hepatitis B Surface Antigen) Blood/Oral Fluid Test Product Overview 10

Asante Rapid Hepatitis C (Anti-Hepatitis C Antibody) Blood/Oral Fluid Test 11

Asante Rapid Hepatitis C (Anti-Hepatitis C Antibody) Blood/Oral Fluid Test Product Overview 11

Asante Rapid HIV-1 Recency (or Incidence) Assay 12

Asante Rapid HIV-1 Recency (or Incidence) Assay Product Overview 12

Rapid Anti-Hepatitis B Ab Blood/Oral Fluid Test 13

Rapid Anti-Hepatitis B Ab Blood/Oral Fluid Test Product Overview 13

Rapid Oral Fluid HIV Test 14

Rapid Oral Fluid HIV Test Product Overview 14

Rapid Syphilis Oral Fluid Test 15

Rapid Syphilis Oral Fluid Test Product Overview 15

Sedia Biosciences Corp-Key Competitors 16

Sedia Biosciences Corp-Key Employees 17

Sedia Biosciences Corp-Locations And Subsidiaries 18

Head Office 18

Other Locations & Subsidiaries 18

Recent Developments 19

Sedia Biosciences Corp, Recent Developments 19

Aug 30, 2016: Sedia Biosciences Awarded Additional USD1.8 M NIH Grant for Novel Rapid HIV Test for Recent Infections 19

Sep 21, 2015: Sedia Biosciences Expands Its HIV-1 LAg-Avidity Assay for Recent HIV-1 Infections to Dried Blood Spot Specimens 19

Oct 23, 2014: Independent Study Shows Sedia's New HIV-1 LAg-Avidity Test is Top Performing Incidence Assay 20

Aug 18, 2014: NIH Awards Sedia Biosciences USD195,490 SBIR Grant for Rapid HIV-1 Incidence Assay 20

Aug 13, 2014: Sedia Biosciences Launches Asante DNA, A New DNA Specimen Collection Kit 21

Feb 12, 2014: Sedia Biosciences Receives USD1.0 Million NIH Grant for New HIV Diagnostic Assay 21

Appendix 23

Methodology 23

About GlobalData 26

Contact Us 26

Disclaimer 26

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Sedia Biosciences Corp Pipeline Products by Equipment Type 5

Sedia Biosciences Corp Pipeline Products by Development Stage 8

List of Tables

Sedia Biosciences Corp Pipeline Products and Ongoing Clinical Trials Overview 4

Sedia Biosciences Corp Pipeline Products by Equipment Type 5

Sedia Biosciences Corp Pipeline Products by Indication 5

Sedia Biosciences Corp, Key Facts 6

Sedia Biosciences Corp, Major Products and Services 7

Sedia Biosciences Corp Number of Pipeline Products by Development Stage 8

Sedia Biosciences Corp Pipeline Products Summary by Development Stage 9

Asante Rapid Hepatitis B sAg (Hepatitis B Surface Antigen) Blood/Oral Fluid Test-Product Status 10

Asante Rapid Hepatitis B sAg (Hepatitis B Surface Antigen) Blood/Oral Fluid Test-Product Description 10

Asante Rapid Hepatitis C (Anti-Hepatitis C Antibody) Blood/Oral Fluid Test-Product Status 11

Asante Rapid Hepatitis C (Anti-Hepatitis C Antibody) Blood/Oral Fluid Test-Product Description 11

Asante Rapid HIV-1 Recency (or Incidence) Assay-Product Status 12

Asante Rapid HIV-1 Recency (or Incidence) Assay-Product Description 12

Rapid Anti-Hepatitis B Ab Blood/Oral Fluid Test-Product Status 13

Rapid Anti-Hepatitis B Ab Blood/Oral Fluid Test-Product Description 13

Rapid Oral Fluid HIV Test-Product Status 14

Rapid Oral Fluid HIV Test-Product Description 14

Rapid Syphilis Oral Fluid Test-Product Status 15

Rapid Syphilis Oral Fluid Test-Product Description 15

Sedia Biosciences Corp, Key Employees 17

Sedia Biosciences Corp, Subsidiaries 18

Glossary 25

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Sekisui Diagnostics LLC

InQ Biosciences Corporation

Helicos BioSciences Corporation

ISK Biosciences Corporation

AxCell Biosciences Corp

LEAP Biosciences Corp

Sedia Biosciences Corp, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand